Diabetes Drugs

<span style="font-weight: 400;">A federal court in New York <a href="http://www.courthousenews.com/wp-content/uploads/2019/10/diabetes.pdf"><strong>dismissed</strong></a> all but one claim against a pharmaceutical company in a suit claiming it inflated the prices of two diabetes drugs. The purchasers monopoly claims may continue, but their antitrust claims fail. </span>

NEW YORK – A federal court in New York dismissed all but one claim against a pharmaceutical company in a suit claiming it inflated the prices of two diabetes drugs. The purchasers’ monopoly claims may continue, but their antitrust claims fail.

Categories / Business, Consumers

Subscribe to our free newsletters

Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.